RARE
#1641
Ultragenyx Pharmaceutical Inc. - Common Stock
33.2 2 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.77%
Monthly Change
+34.93%
6 month change
+39.11%
Year Change
+13.22%
Previous Close
33.8 2
Open
33.2 2
Low
33.2 2
High
33.2 2
Volume
120
Financials
- Market Capitalization 3.27 B
- Employee 1 371
- Founded 2010
- CEO Emil Kakkis
- Website www.ultragenyx.com
- Headquarter Delaware, United States
- FIGI BBG001RWPDW6
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.95
Price to sales ratio
3.37
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1617 |  DYN Dyne Therapeutics, Inc. - Common Stock | 23.64 USD | +0.94% | +3.68% | +28.06% | +0.98% | 3.38 B USD | ||
| 1621 |  ADPT Adaptive Biotechnologies Corporation - Common Stock | 21.02 USD | -0.19% | -1.64% | +14.36% | +21.78% | 3.36 B USD | ||
| 1661 |  BEAM Beam Therapeutics Inc. - Common Stock | 31.00 USD | -5.14% | -15.07% | +3.85% | +45.27% | 3.19 B USD | ||
| 1663 |  IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.15 USD | -2.27% | -7.85% | +22.83% | +10.96% | 3.18 B USD |
Frequently asked questions about Ultragenyx Pharmaceutical Inc. - Common Stock
What is the Ultragenyx Pharmaceutical Inc. - Common Stock stock price today?
The current price of Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) is 33.22. Over the past 24 hours, the stock has changed by -1.77%. Follow the RARE chart for real-time price dynamics.
What is the stock ticker of Ultragenyx Pharmaceutical Inc. - Common Stock?
Ultragenyx Pharmaceutical Inc. - Common Stock trades under the ticker RARE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ultragenyx Pharmaceutical Inc. - Common Stock stock going up?
RARE has changed by -7.54% over the last week, +34.93% over the last month, and +13.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ultragenyx Pharmaceutical Inc. - Common Stock net income for the last quarter?
Ultragenyx Pharmaceutical Inc. - Common Stock reported net income of -185 M for the last quarter. The previous quarter showed -128.64 M, which means net income changed by -43.82%.
How many employees does Ultragenyx Pharmaceutical Inc. - Common Stock have?
As of the latest available data, Ultragenyx Pharmaceutical Inc. - Common Stock has 1 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ultragenyx Pharmaceutical Inc. - Common Stock EBITDA?
Ultragenyx Pharmaceutical Inc. - Common Stock EBITDA is -131 M, and its EBITDA margin is -96.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ultragenyx Pharmaceutical Inc. - Common Stock stock?
You can buy Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ultragenyx Pharmaceutical Inc. - Common Stock stock?
Investing in Ultragenyx Pharmaceutical Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RARE chart and related analysis on metatrader.com as part of your research.